لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pisters KM, Vallières E, Crowley JJ, Franklin WA, Bunn PA Jr, Ginsberg RJ, Putnam JB Jr, Chansky K, Gandara D, Pisters, Katherine M W, Vallières, Eric, Crowley, John J, Franklin, Wilbur A, Bunn, Paul A Jr, Ginsberg, Robert J, Putnam, Joe B Jr, Chansky, Kari, Gandara, David

المصدر: Journal of Clinical Oncology; 4/10/2010, Vol. 28 Issue 11, p1843-1849, 7p

المؤلفون: Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA

المصدر: Journal of Clinical Oncology; Dec2007, Vol. 25 Issue 34, p5506-5518, 13p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Fung AS; Department of Oncology, Queen's University, Canada; Princess Margaret Cancer Centre, University Health Network, Canada., Graham DM; Princess Margaret Cancer Centre, University Health Network, Canada; Division of Medical Oncology, University of Toronto, Canada; The Christie NHSFoundation Trust, Manchester, UK., Chen EX; Princess Margaret Cancer Centre, University Health Network, Canada; Division of Medical Oncology, University of Toronto, Canada., Stockley TL; Division of Clinical Laboratory Genetics, University Health Network, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada; Advanced Molecular Diagnostics Laboratory, University Health Network, Canada., Zhang T; Division of Clinical Laboratory Genetics, University Health Network, Canada; Advanced Molecular Diagnostics Laboratory, University Health Network, Canada., Le LW; Princess Margaret Cancer Centre, University Health Network, Canada., Albaba H; Princess Margaret Cancer Centre, University Health Network, Canada., Pisters KM; Princess Margaret Cancer Centre, University Health Network, Canada; MD Anderson Cancer Centre, Houston, TX, United States., Bradbury PA; Princess Margaret Cancer Centre, University Health Network, Canada; Division of Medical Oncology, University of Toronto, Canada., Trinkaus M; Division of Medical Oncology, University of Toronto, Canada; Markham Stouffville Hospital, Markham, Canada., Chan M; Division of Medical Oncology, University of Toronto, Canada; Trillium Health Partners, Mississauga, Canada., Arif S; Division of Medical Oncology, University of Toronto, Canada; Trillium Health Partners, Mississauga, Canada., Zurawska U; Division of Medical Oncology, University of Toronto, Canada; St. Joseph's Health Centre, Toronto, Canada., Rothenstein J; Division of Medical Oncology, University of Toronto, Canada; RS McLaughlin Durham Cancer Centre, Oshawa, Canada., Zawisza D; Princess Margaret Cancer Centre, University Health Network, Canada., Effendi S; Princess Margaret Cancer Centre, University Health Network, Canada., Gill S; Princess Margaret Cancer Centre, University Health Network, Canada., Sawczak M; Princess Margaret Cancer Centre, University Health Network, Canada., Law JH; Princess Margaret Cancer Centre, University Health Network, Canada., Leighl NB; Princess Margaret Cancer Centre, University Health Network, Canada; Division of Medical Oncology, University of Toronto, Canada. Electronic address: Natasha.Leighl@uhn.ca.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Jul; Vol. 157, pp. 21-29. Date of Electronic Publication: 2021 May 24.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Benzimidazoles ; Carboplatin/therapeutic use ; Humans ; Mitogen-Activated Protein Kinase Kinases/therapeutic use ; Pemetrexed/therapeutic use ; Treatment Outcome

المؤلفون: O'Kane GM; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address: okaneg@tcd.ie., Bradbury PA; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Feld R; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Leighl NB; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Liu G; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Pisters KM; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Kamel-Reid S; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Tsao MS; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada., Shepherd FA; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Jul; Vol. 109, pp. 137-144. Date of Electronic Publication: 2017 Apr 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*genetics , ErbB Receptors/*genetics , Lung Neoplasms/*genetics , Mutation/*genetics , Protein Kinase Inhibitors/*therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy ; Drug Resistance ; Humans ; Incidence ; Lung Neoplasms/drug therapy ; Treatment Outcome

المؤلفون: Halasz LM; Department of Radiation Oncology, University of Washington, Seattle, Washington., Uno H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hughes M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., D'Amico T; Department of Surgery, Duke Cancer Institute, Durham, North Carolina., Dexter EU; Department of Surgery, Roswell Park Cancer Institute, Buffalo, New York.; University of Buffalo, Buffalo, New York., Edge SB; Department of Surgery, Roswell Park Cancer Institute, Buffalo, New York.; University of Buffalo, Buffalo, New York., Hayman JA; University of Michigan, Ann Arbor, Michigan., Niland JC; Information Sciences, City of Hope, Duarte, California., Otterson GA; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Pisters KM; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Theriault R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Weeks JC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Punglia RS; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

المصدر: Cancer [Cancer] 2016 Jul 01; Vol. 122 (13), pp. 2091-100. Date of Electronic Publication: 2016 Apr 18.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*radiotherapy , Brain Neoplasms/*secondary , Breast Neoplasms/*radiotherapy , Carcinoma, Non-Small-Cell Lung/*radiotherapy , Cranial Irradiation/*statistics & numerical data , Lung Neoplasms/*radiotherapy , Radiosurgery/*statistics & numerical data, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Propensity Score ; Survival Analysis ; Treatment Outcome